Skip to main content
Clinical Trials/CTRI/2024/07/069904
CTRI/2024/07/069904Not yet recruitingPhase 3 4

Comparative study of Haemodynamic parameters of Intravenous Oxytocin and Intravenous Carbetocin in patients undergoing Elective Caesarean section-One year Randomised Control Clinical Study

Dr Vanshika Saranga1 site in 1 country70 target enrollmentStarted: July 15, 2024Last updated:

Trial Snapshot

Phase
Phase 3 4
Status
Not yet recruiting
Sponsor
Enrollment
70
Locations
1
Primary Endpoint
To compare the maternal hemodynamic changes for oxytocin and carbetocin(effect on heart rate and blood pressure)during elective Caesarean section

Study Overview

Brief Summary

This study is to compare haemodynamic responses following intravenous injection of oxytocin and carbetocin in patients undergoing elective caesarean section under subarachnoid block

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 35.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • American Society of Anaethesiologists physical status II Patients undergoing elective caesarean section under subarachnoid block provides consent.

Exclusion Criteria

  • Presence of hypertension,preeclampsia,cardiac,renal or liver diseases, epilepsy and dearranged coagulation profile patients undergoing general anaesthesia and emergency LSCS patient who are unable or unwilling to give consent women with history of hypersensitivity to carbetocin patients who do not fulfil inclusion criteria.

Outcomes

Primary Outcomes

To compare the maternal hemodynamic changes for oxytocin and carbetocin(effect on heart rate and blood pressure)during elective Caesarean section

Time Frame: 0min,3min,6min,9min,12min,15min,18min,21min,24min,27min,30min,33min,36min,39min,42min,45min

Secondary Outcomes

  • To assess the effective uterotonic action of oxytocin & carbetocin in terms of estimation of preoperative & postoperative HB estimation(48hours after delivery)

Investigators

Sponsor
Dr Vanshika Saranga
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Vanshika Saranga

KLE Dr Prabhakar Kore Hospital and MRC

Study Sites (1)

Loading locations...

Similar Trials